Trial intelligence / Profile preview

Progestin-Induced Shedding in Clomiphene Cycles for PCOS

NCT01966575Phase 4Withdrawn

Sponsor
University of British Columbia
Start
Oct 2013
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of medroxyprogesterone acetate in polycystic ovary syndrome (PCOS), infertility, sponsored by University of British Columbia. Planned start Oct 2013; status: withdrawn.

02

Drugs

medroxyprogesterone acetate
03

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on NCT01966575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01966575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call